Assessing the Response Rate of Neo-adjuvant Taxotere and Trastuzumab in Nigerian Women With Breast Cancer

Conditions:   Breast Cancer;   Breast Cancer Female;   HER2-positive Breast Cancer;   Breast Cancer Stage II;   Breast Cancer Stage III Interventions:   Drug: Docetaxel;   Drug: Herceptin;   Drug: FEC;   Drug: Tamoxifen;   Drug: Letrozole;   Drug: LHRH agonist Sponsor:   University of Chicago Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials